CytoDyn Inc. (OTCMKTS:CYDY – Get Free Report) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.23 and traded as low as $0.23. CytoDyn shares last traded at $0.24, with a volume of 1,339,990 shares.
CytoDyn Stock Performance
The company’s 50 day moving average price is $0.23 and its 200 day moving average price is $0.17. The company has a market cap of $276.04 million, a price-to-earnings ratio of -22.40 and a beta of -0.28.
CytoDyn Company Profile
CytoDyn Inc, a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer.
Read More
- Five stocks we like better than CytoDyn
- Election Stocks: How Elections Affect the Stock Market
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Health Care Stocks Explained: Why You Might Want to Invest
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Using the MarketBeat Dividend Tax Calculator
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for CytoDyn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CytoDyn and related companies with MarketBeat.com's FREE daily email newsletter.
